PHARMACEUTICAL DOSAGE FORM COMPRISING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL-)-4-PHENYL-4,9 -DIHYDRO-3H-SPIRO[CYCLOHEXANE-1, 1 -PYRANO[3,4,B]INDOL]-4-AMINE
The invention relates to a pharmaceutical dosage form for administration twice daily, once daily or less frequently, which contains 6"-fluoro-(N-methyl- or N,N-dimethyl)-4-phenyl-4",9"-dihydro-3"H-spiro[cyclohexane-1,1"-pyrano[3,4,b]indol]-4-amine or a physiologically acceptable salt thereof.